MFCD05860813
|
- $160 - $700
- Product name: MFCD05860813
- CAS: 199293-12-4
- MF: C8H5Cl2NOS
- MW: 234.1
- EINECS:
- MDL Number:MFCD05860813
- Synonyms:5,7-dichloro-6-methyl-1,3-benzoxazole-2-thiol;5,7-dichloro-6-methyl-3H-1,3-benzoxazole-2-thione;MFCD05860813;2(3H)-Benzoxazolethione, 5,7-dichloro-6-methyl-;5,7-Dichloro-6-methylbenzo[d]oxazole-2-thiol;5,7-Dichloro-6-methyl-benzooxazole-2-thiol
4 prices
Selected condition：
Brand
- Crysdot
- Matrix Scientific
Package
- 0.500g
- 1g
- 5g
- ManufacturerCrysdot
- Product numberCD11170264
- Product description5,7-Dichloro-6-methylbenzo[d]oxazole-2-thiol 97%
- Packaging5g
- Price$527
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number156874
- Product description5,7-Dichloro-6-methyl-1,3-benzoxazole-2-thiol
- Packaging0.500g
- Price$160
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number156874
- Product description5,7-Dichloro-6-methyl-1,3-benzoxazole-2-thiol
- Packaging1g
- Price$200
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number156874
- Product description5,7-Dichloro-6-methyl-1,3-benzoxazole-2-thiol
- Packaging5g
- Price$700
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Crysdot | CD11170264 | 5,7-Dichloro-6-methylbenzo[d]oxazole-2-thiol 97% | 5g | $527 | 2021-12-16 | Buy |
| Matrix Scientific | 156874 | 5,7-Dichloro-6-methyl-1,3-benzoxazole-2-thiol | 0.500g | $160 | 2021-12-16 | Buy |
| Matrix Scientific | 156874 | 5,7-Dichloro-6-methyl-1,3-benzoxazole-2-thiol | 1g | $200 | 2021-12-16 | Buy |
| Matrix Scientific | 156874 | 5,7-Dichloro-6-methyl-1,3-benzoxazole-2-thiol | 5g | $700 | 2021-12-16 | Buy |
Properties
Boiling point :332.4±52.0 °C(Predicted)
Density :1.61±0.1 g/cm3(Predicted)
pka :9.61±0.20(Predicted)
Density :1.61±0.1 g/cm3(Predicted)
pka :9.61±0.20(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|